Clinical development of anticancer agents--a National Cancer Institute perspective

Cancer care in transgender and gender-diverse persons: results from two national surveys among providers and health service users by the Italian Association of Medical Oncology.

ESMO open·2023

How liquid biopsies can change clinical practice in oncology.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort.

Oncogene·2016

Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I database.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.

Cancer treatment reports·1987

IV melphalan in children.

Cancer treatment reports·1987

Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.

Cancer treatment reports·1987

Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.

Cancer treatment reports·1987

Doxorubicin distribution in human breast cancer.

Cancer treatment reports·1987

Phase I study of echinomycin.

Cancer treatment reports·1987

The protective effect of chemical and natural compounds against amiodarone induced toxicity: A systematic review.

Biochemistry and biophysics reports·2026

RAS-targeted therapies for pancreatic cancer.

ESMO gastrointestinal oncology·2026

[Utility of Imaging Mass Cytometry in Spatial Analysis of Non-Small Cell Lung Cancer].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

Immune checkpoint knockout screen reveals TIGIT-CD155 interaction as a significant modulator of adapter CAR-T cell function in acute myeloid leukemia.

Oncoimmunology·2026

Precision Medicine for Somatic Mutation-Driven Vascular Anomalies.

The British journal of dermatology·2026

Disulfiram Attenuates Adenine-Induced Renal Fibrosis by Modulating Inflammatory and Immunometabolic Responses.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

Related Experiment Videos

Clinical development of anticancer agents--a National Cancer Institute perspective

Related Concept Videos

Cancer care in transgender and gender-diverse persons: results from two national surveys among providers and health service users by the Italian Association of Medical Oncology.

How liquid biopsies can change clinical practice in oncology.

Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer.

Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort.

Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial.

Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I database.

Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.

IV melphalan in children.

Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.

Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.

Doxorubicin distribution in human breast cancer.

Phase I study of echinomycin.

The protective effect of chemical and natural compounds against amiodarone induced toxicity: A systematic review.

RAS-targeted therapies for pancreatic cancer.

[Utility of Imaging Mass Cytometry in Spatial Analysis of Non-Small Cell Lung Cancer].

Immune checkpoint knockout screen reveals TIGIT-CD155 interaction as a significant modulator of adapter CAR-T cell function in acute myeloid leukemia.

Precision Medicine for Somatic Mutation-Driven Vascular Anomalies.

Disulfiram Attenuates Adenine-Induced Renal Fibrosis by Modulating Inflammatory and Immunometabolic Responses.

Related Experiment Videos

Clinical development of anticancer agents--a National Cancer Institute perspective

Related Concept Videos

Related Articles